<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Ddregpharmausa - Latest News</title>
<link href="https://news.prfree.org/rss/ddregpharmausa/latest.xml"></link>
<updated>2026-08-06T01:25:14+00:00</updated>
<id>urn:uuid:116ad7bb-61a6-5251-e5a2-e0f871c0c4d6</id>
<entry>
<title>Health Canada Drug Approval Pathways 2025: A Complete Guide for Global Pharma Companies</title>
<link href="https://news.prfree.org/@ddregpharmausa/health-canada-drug-approval-pathways-2025-a-complete-guide-for-global-pharma-companies-mkkpnnymjcjz"></link>
<id>urn:uuid:7fec170e-4e75-4f28-6e97-707d2707a2f8</id>
<summary type="html"><![CDATA[In 2025, Health Canada has recast its methodology for overseeing pharmaceuticals, biologics, and innovative therapies.]]></summary>
<updated>2025-10-24T10:42:54+00:00</updated>
</entry>
<entry>
<title>Post-Market Drug Safety: From ICSRs to Real-World Data Integration in Global Pharmacovigilance Systems</title>
<link href="https://news.prfree.org/@ddregpharmausa/post-market-drug-safety-from-icsrs-to-real-world-data-integration-in-global-pharmacovigilance-systems-09w2ss00k6d8"></link>
<id>urn:uuid:c97eb2fc-137f-8260-00b9-8b6f4ddf01a7</id>
<summary type="html"><![CDATA[Post-Market Drug Safety: From ICSRs to Real-World Data Integration in Global Pharmacovigilance Systems
The lifecycle of a medicinal product only starts after approval.]]></summary>
<updated>2025-10-24T10:40:25+00:00</updated>
</entry>
<entry>
<title>LatAm Regulatory Harmonization: Why 2025 Is a Turning Point</title>
<link href="https://news.prfree.org/@ddregpharmausa/latam-regulatory-harmonization-why-2025-is-a-turning-point-kqrufphivsf2"></link>
<id>urn:uuid:7c90a372-e9a9-cb04-598e-e6466a12349e</id>
<summary type="html"><![CDATA[As regional agencies deepen collaboration through platforms like PAHO and MERCOSUR, 2025 stands as the year when regulatory harmonization.]]></summary>
<updated>2025-10-24T10:10:56+00:00</updated>
</entry>
</feed>